Browsing Technical documents and research evidence on COVID-19 by Title
Now showing items 416-435 of 1749
-
COVID-19: Guidelines for Communicating about Coronavirus Disease 2019. A Guide for Leaders
(2020-06-26)Introduction: The outbreak of coronavirus 2019 disease (COVID-19) in Hubei, China, and the introduction of the virus into the Region of the Americas highlight the urgent need for clear, concise and consistent communication. ... -
COVID-19: Operational guidance for maintaining essential health services during an outbreak. Interim guidance, 25 March 2020
(2020-03-25)Introduction and overview: Health systems are being confronted with rapidly increasing demand generated by the COVID-19 outbreak. When health systems are overwhelmed, both direct mortality from an outbreak and indirect ... -
COVID-19: press releases and what you need to know
(2020)Ministry of Public Health website that includes access to files organized in two categories: press releases and "what you need to know". -
COVID-19: Public Compliance with and Public Support for Stay-at-Home Mitigation Strategies
(2020-04-24)Objectives: Governments worldwide have recommended unprecedented measures to mitigate the coronavirus disease 2019 (COVID-19) pandemic. As pressure mounts to scale back these measures, understanding public compliance with ... -
Covid-19: remote consultations
(2020-03-25)This graphic, intended for use in a primary care setting, is based on data available in March 2020, much of which is from hospital settings in China. It will be revised as more relevant data emerges. -
COVID-19: Roche Antibody Test – 14th May
(2020-05-14)What do sensitivity and specificity tell us? Sensitivity tells us the proportion of people who test positive, out of the population who should have tested positive. In this case, a sensitivity of 100% tells us that everybody ... -
The COVID-NMA initiative: A living mapping and living systematic review of Covid-19 trials
(2020)COVID-NMA is an international research initiative supported by the WHO and Cochrane. We provide a living mapping of COVID-19 trials available through interactive data visualizations. We are also conducting living evidence ... -
Covid2019 / SARSCoV2 coronavirus antivirals
(2020-04-20)Includes: Interferons, Nucleoside analogs, Protease inhibitors, Furin Convertase Cleavage inhibitors, Reverse transcriptase inhibitors, RNA Polymerase/Synthesis Inhibitors, Neuraminidase inhibitors, Angiotensin II receptor ... -
COVID‐19 and gastrointestinal endoscopies: current insights and emergent strategies
(2020-04-13)A new coronavirus emerged in December 2019 in Wuhan city of China, named as the severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2), and disease was called as coronavirus disease‐2019 (COVID‐19). The infection due ... -
COVID‐19 in a Designated Infectious Diseases Hospital Outside Hubei Province, China
(2020-04-02)[Abstract]. Background: The clinical characteristics of novel coronavirus disease (COVID‐2019) patients outside the epicenter of Hubei province are less understood. Methods: We analyzed the epidemiological and clinical ... -
COVID‐19 in Seattle—Early lessons learned
(2020-03-25)The coronavirus disease 2019 (COVID‐19) pandemic has rapidly evolved and now dominates the attention and full efforts of the emergency medicine community, both domestic and abroad. Seattle is the site of the initial diagnosed ... -
The covid‐19 pandemic, personal protective equipment, and respirator: a narrative review
(2020-06-08)The coronavirus disease 2019 (COVID‐19) pandemic has touched almost every continent. Personal protective equipment (PPE) is the final line of protection of healthcare workers (HCW). There is variation as well as controversy ... -
COVID‐19 treatment by repurposing drugs until the vaccine is in sight
(2020-03-29)Corona virus disease (COVID-19) has created pandemic in the world as declared by WHO on March 12, 2020. It is a viral disease caused by SARS-CoV 2 virus and has affected large populations in over 120 countries. There is ... -
Creating a Palliative Care Inpatient Response Plan for COVID19 – The UW Medicine Experience
(2020-03-24)[Abstract]. Introduction: The COVID-19 pandemic is stressing healthcare systems throughout the world. Significant numbers of patients are being admitted to the hospital with severe illness, often in the setting of advanced ... -
Critical preparedness, readiness and response actions for COVID-19 - 7 March 2020
All countries should increase their level of preparedness, alert and response to identify, manage and care for new cases of COVID-19. Countries should prepare to respond to different public health scenarios, recognizing ... -
Cross-infection enhancement among African flaviviruses by immune mouse ascitic fluids
(2014)Cross-infection enhancement of seven African flaviviruses by subneutralising concentrations of antibody in immune ascitic fluids was investigated in P388D1 cell culture. Infection by all the seven flaviviruses tested was ... -
CT features of SARS-CoV-2 pneumonia according to clinical presentation: a retrospective analysis of 120 consecutive patients from Wuhan city
(2020-04-11)[Abstract]. Objectives: To characterize the chest computed tomography (CT) findings of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) according to clinical severity. We compared the CT features of common cases ...